Mark Udell

Insider Reports History

Location
Oxnard, CA
Signature
/s/ Mark Udell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Udell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cure Pharmaceutical Holding Corp. Chief Accounting Officer Stock Option 150,000 01 Jan 2018 Direct

Insider Reports Filed by Mark Udell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVRW Cure Pharmaceutical Holding Corp. 01 Jan 2018 1 $0 4 Chief Accounting Officer 27 May 2021, 19:40